Venture NAV Tracker / Private company
Long Grove Pharmaceuticals, LLC
Headquarters—
Founded—
Last known round—
Reported valuation—
Cross-fund comparison
Current disclosed marks
One latest disclosed debt mark per fund.
| Fund | Security type / basis | Principal | Fair value | FV / principal | Rate | Maturity | Mark age vs round | Non-accrual |
|---|---|---|---|---|---|---|---|---|
| HRZNHorizon Technology Finance Corp | senior secured loanFair Value — Term Loan | $10.4MMar 31, 2026 · source ↗ | $10.2MMar 31, 2026 · source ↗ | 98.0%Mar 31, 2026 · source ↗ | Cash rate 7.67%; Index 1-month SOFR; Margin 4.00%; Floor 6.00%Mar 31, 2026 · source ↗ | Feb 27, 2031Mar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | NoMar 31, 2026 · source ↗ |
Historical marks
Reported fair value by fund
Each bar is a disclosed position-quarter.